Statistics for Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials
Total visits
views | |
---|---|
Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials | 175 |
Total visits per month
views | |
---|---|
June 2024 | 1 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
File Visits
views | |
---|---|
Sayar_2019_combination.pdf | 332 |
Top country views
views | |
---|---|
United States | 133 |
Ukraine | 6 |
Germany | 5 |
Sweden | 5 |
Russia | 4 |
France | 3 |
Canada | 2 |
Switzerland | 1 |
China | 1 |
United Kingdom | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 46 |
Fairfield | 20 |
Houston | 14 |
White Plains | 7 |
Cambridge | 6 |
Jacksonville | 6 |
Kiev | 5 |
Kiez | 5 |
Stockholm | 5 |
Ann Arbor | 2 |
Paris | 2 |
San Francisco | 2 |
Seattle | 2 |
Toronto | 2 |
Baltimore | 1 |
Beijing | 1 |
Brooklyn | 1 |
Bryansk | 1 |
Carmel | 1 |
Cointrin | 1 |
Kharkov | 1 |
Mesa | 1 |
Nanterre | 1 |
Northville | 1 |
Philadelphia | 1 |
Redwood City | 1 |
Saint Petersburg | 1 |
Seremban | 1 |
Zheleznogorsk | 1 |